[ORGANIZATION]
Kuehn Law, PLLC
Featured in 2 tracked stories · first seen
Situations
Disc Medicine bitopertin regulatory and clinical status
2 clusters · 8 sources · last updated
Latest: Disc Medicine reports successful Phase 3 trial for EPP drug
Disc Medicine Inc. has faced scrutiny regarding its experimental treatment for erythropoietic protoporphyria (EPP), bitopertin. Following a February decision by the U.S. Food and Drug Administration (FDA) to decline appr
Also covered in
-
Kuehn Law Initiates Shareholder Lawsuits Targeting iRhythm, Five9, and Firefly Aerospace
[BUSINESS] · 3 sources ·